Institutional investors purchased a net $4.6 million shares of VRX during the quarter ended December 2017 and now own 51.93% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
TB ALTERNATIVE ASSETS LTD. Bought 216.1 Thousand shares of Valeant Pharmaceuticals I...
ANDRA AP-FONDEN Bought 104.5 Thousand shares of Valeant Pharmaceuticals I...